1. Dark under the Lamp: Neglected Biological Pollutants in the Environment Are Closely Linked to Lung Cancer
   Dongjie Wang et al, 2024, IJMS CrossRef
2. Synthetic Routes and Clinical Application of Representative Small-Molecule EGFR Inhibitors for Cancer Therapy
   Ya-Tao Wang et al, 2024, Molecules CrossRef
3. Chemical Scaffolds for the Clinical Development of Mutant-Selective and Reversible Fourth-Generation EGFR-TKIs in NSCLC
   Emiliano Laudadio et al, 2024, ACS Chem. Biol. CrossRef
4. Belamcanda chinensis extract inhibits non-small cell lung cancer proliferation and induces apoptosis via inhibiting the MAPK (Ras/Raf) and Akt pathways
   Chong Ma et al, 2024, Heliyon CrossRef
5. Hepatotoxicity of epidermal growth factor receptor - tyrosine kinase inhibitors (EGFR-TKIs)
   Lulin Zhu et al, 2024, Drug Metabolism Reviews CrossRef
6. Meta-analysis of Targeted Therapies in EGFR-mutated Non–Small Cell Lung Cancer
   Zaheer Qureshi et al, 2024 CrossRef
7. Successful rapid improvement of acute respiratory distress syndrome induced by EGFR-mutated non-small cell lung cancer with almonertinib: a case report
   Cheng Sun et al, 2024, BMC Pulm Med CrossRef
8. Advances in Cancer Therapy: A Comprehensive Review of CDK and EGFR Inhibitors
   Mohammed Hawash, 2024, Cells CrossRef
9. Identification of expression profiles and transcription factors during EGFR‐TKI acquired resistance in LUAD
   Lili Feng et al, 2024, Precision Medical Sciences CrossRef
10. The Agonistic Activity of the Human Epidermal Growth Factor is Reduced by the D46G Substitution
    Anastasia Aleksandrovna Akunevich et al, 2024, PPL CrossRef
11. Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
    Byoung C. Cho et al, 2024, N Engl J Med CrossRef
12. EGFR-Targeted Therapies: A Literature Review
    Calista Sha et al, 2024, JCM CrossRef
13. Discovery of 3-(2-aminobenzo[d]thiazol-5-yl) benzamide derivatives as potent anticancer agents via ROR1 inhibition
    Fang Luo et al, 2024, Bioorganic & Medicinal Chemistry CrossRef
14. Erlotinib Improves the Response of Glioblastoma Cells Resistant to Photodynamic Therapy
    Karen Olthoff et al, 2024, Brain Sciences CrossRef
15. Regulation of keratinocyte barrier function and inflammatory response by the EGFR-STAT3 Pathway: Potential therapeutic implications of osimertinib and afatinib
    Xin Chen et al, 2025, Cytokine CrossRef
16. What is the optimal first-line regimen for advanced non-small cell lung cancer patients with epidermal growth factor receptor mutation: a systematic review and network meta-analysis
    Wengang Zhang et al, 2024, BMC Pulm Med CrossRef
17. Molecular Mechanisms, Diagnoses, and Treatments of Respiratory Diseases
    Te-Chun Shen, 2024, Biomedicines CrossRef
18. Gene Editing in ErbB/HER Family-Mediated Cancer Immunology
    Ling Yin, 2025 CrossRef